Substitution of Pancreatic Enzymes: Basic Information by In Vitro Investigations

  • M. Otte
  • P. Ridder

Abstract

Substitution of pancreatic enzymes is necessary in only few patients. Not until the secretory capacity has been reduced to about 10%, when maldigestion usually becomes manifest, does steatorrhoea appear [1, 7]. Such extensive insufficiency of the pancreas normally develops in patients with advanced chronic pancreatitis, cystic fibrosis, after resective operations of the pancreas, and sometimes in patients with pancreatic carcinoma. Only those patients with a daily weight of faeces of more than 250 g and/or with a loss of weight, although food intake is sufficient, require treatment [8].

Keywords

Lipase Pancreatitis Acidity Cimetidine Prep 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    DiMagno EP, Go VLW, Summerskill WHJ (1973) Relation between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815PubMedCrossRefGoogle Scholar
  2. 2.
    DiMagno EP, Malagelada JR, Go VLW, Moertel CG (1977) Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two dosage schedules. N Engl J Med 296:1318–1322PubMedCrossRefGoogle Scholar
  3. 3.
    Dutta SK, Tilley DK (1983) The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency. J Clin Gastroenterol 5:51–54PubMedCrossRefGoogle Scholar
  4. 4.
    Graham DY (1977) Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relation between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts. N Engl J Med 296:1314–1317PubMedCrossRefGoogle Scholar
  5. 5.
    Heizer WD, Cleaveland CR, Iber FL (1965) Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 116:261–270PubMedGoogle Scholar
  6. 6.
    Ihse I, Lilja P (1979) Pancreatic enzymic activities of commercial pancreatic enzyme preparations incubated in human small intestinal juice. Digestion 19:48–51PubMedCrossRefGoogle Scholar
  7. 7.
    Lankisch PG, Gutte G, Lembcke B (1982) Functioning reserve capacity of the exocrine pancreas. Digestion 25:48–49CrossRefGoogle Scholar
  8. 8.
    Lankisch PG, Creutzfeldt W (1984) Therapy of exocrine and endocrine pancreatic insufficiency. Clin Gastroenterol 13:985–999PubMedGoogle Scholar
  9. 9.
    Meyer JH (1977) The ins and outs of oral pancreatic enzymes. N Engl J Med 296:1347–1348PubMedCrossRefGoogle Scholar
  10. 10.
    Möller H (1979) Vergleichende Untersuchungen von Pankreatin-Fertigarzneimitteln. Pharmazeutische Zeitung 124:2279–.2286Google Scholar
  11. 11.
    Pairent FW, Howard JM (1975) Pancreatic exocrine insufficiency. IV. The enzyme content of commercial pancreatic supplements. Arch Surg 110:739 –. 741PubMedCrossRefGoogle Scholar
  12. 12.
    Regan PT, Malagelada JR, DiMagno EP, Glanzman SL, Go VLW (1977) Comparative effects of antacids, Cimetidine, and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–.858CrossRefGoogle Scholar
  13. 13.
    Regan PT, DiMagno EP (1979) The medical management of malabsorption. Mayo Clin Proc 54:267–274PubMedGoogle Scholar
  14. 14.
    Ribet A, Balas D, Bommelaer G, Pradayrol L, Varignon M (1979) Activité enzymatique in vitro de différents etraits pancréatiques. Gastroenterol Clin Biol 3:515–520PubMedGoogle Scholar
  15. 15.
    Worning H (1980) The effect of enzyme substitution in patients with pancreatic insufficiency. Scand J Gastroenterol 15:529 –. 533PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • M. Otte
    • 1
  • P. Ridder
    • 1
  1. 1.Medizinische Hochschule LübeckLübeck 1Germany

Personalised recommendations